Evidence map›Paper›PMID 23684611›Full record

ArticleCell reports2013

Two distinct modes of ATR activation orchestrated by Rad17 and Nbs1.

Bunsyo Shiotani, Hai Dang Nguyen, Pelle Håkansson, Alexandre Maréchal, Alice Tse, Hidetoshi Tahara, Lee Zou

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 138 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. ATM priming and end resection-coupled phosphorylation of MRE11 is important for fork protection and replication restart.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Bunsyo ShiotaniMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA. bshiotan@hiroshima-u.ac.jp
Hai Dang Nguyen
Pelle Håkansson
Alexandre Maréchal
Alice Tse
Hidetoshi Tahara
Lee Zou
Massachusetts General Hospital · USHarvard University · USHiroshima University · JP

Funding

Regulation of the ATR Checkpoint Kinase by DNA DamageR01GM076388 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI ZOU, LEE · 2006 to 2018
$4.3M
NIGMS NIH HHS GM076388NIGMS NIH HHS R01 GM076388
6 · The paper itself

Abstract

The ATM- and Rad3-related (ATR) kinase is a master regulator of the DNA damage response, yet how ATR is activated toward different substrates is still poorly understood. Here, we show that ATR phosphorylates Chk1 and RPA32 through distinct mechanisms at replication-associated DNA double-stranded breaks (DSBs). In contrast to the rapid phosphorylation of Chk1, RPA32 is progressively phosphorylated by ATR at Ser33 during DSB resection prior to the phosphorylation of Ser4/Ser8 by DNA-PKcs. Surprisingly, despite its reliance on ATR and TopBP1, substantial RPA32 Ser33 phosphorylation occurs in a Rad17-independent but Nbs1-dependent manner in vivo and in vitro. Importantly, the role of Nbs1 in RPA32 phosphorylation can be separated from ATM activation and DSB resection, and it is dependent upon the interaction of Nbs1 with RPA. An Nbs1 mutant that is unable to bind RPA fails to support proper recovery of collapsed replication forks, suggesting that the Nbs1-mediated mode of ATR activation is important for the repair of replication-associated DSBs.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell Cycle ProteinsCell Line, TumorCheckpoint Kinase 1DNA-Binding ProteinsDNA Breaks, Double-StrandedDNA ReplicationDNA, Single-StrandedEndodeoxyribonucleasesHEK293 CellsHeLa CellsHumansNuclear ProteinsPhosphorylationAtaxia Telangiectasia Mutated ProteinsATR protein, humanCarrier ProteinsCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanDNA-Binding ProteinsDNA, Single-StrandedEndodeoxyribonucleasesNBN protein, humanNuclear ProteinsProtein KinasesRad17 protein, humanRBBP8 protein, humanReplication Protein ARNA, Small InterferingRPA2 protein, humanTOPBP1 protein, human

Identifiers

PMID23684611
PMCPMC3680100
OpenAlexW1981142961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.